Erratum
for
Goldstein et al., J Clin Oncol 26 (25) 4063-4071.
Journal of Clinical Oncology, Vol 27, No 21 (July 20), 2009: pp. 3566
© 2009 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2009.24.7387
ERRATUM
The September 1, 2008, article by Goldstein et al, entitled "Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features" (J Clin Oncol 26:4063–4071, 2008), contained errors.
The Running Head was given as: "21-Gene Assay Compared With Adjuvant!"
While it should have been: "21-Gene Assay Compared With Clinicopathologic Features."
In Figures 2, 3, 4(B & C), and 5(A), the term "Adjuvant!" was used, whereas it should have been "Integrator."
The online version has been corrected in departure from the print.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
|
